In contrast, the significant accumulation of CD3+ T cells, CD4+ T cells, and CD8+ T cells were detected in tumors from inCVAX-treated HCC-bearing mice (right panel of Figures 4a-4c). This evidence concerns the gene CD4 and hepatocellular carcinoma.